Navigation Links
Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
Date:12/18/2007

mplexation

reagents;

-- and gene target inventions, predominantly cancer directed.

Nastech's own IP related to RNA-based therapeutics and diagnostics include the following published patent applications:
-- Compositions and Methods for Lipid and Polypeptide Based siRNA

Intracellular Delivery

-- Compositions and Methods for Complexes of Nucleic Acids and Organic

Cations

-- Cationic Peptides for siRNA Intracellular Delivery

-- Formulations for Intracellular Delivery dsRNA

-- Compositions and Methods Employing Universal-Binding Nucleotides for

Targeting Multiple Gene Variants with a Single siRNA Duplex

-- RNAi Therapeutic for Respiratory Virus Infection

-- Compositions and Methods for Complexes of Nucleic Acids and Peptides

-- Phage Displayed Cell Binding Peptides

-- Dry Powder Compositions for RNA Influenza Therapeutics

-- Nanoparticles for Delivery of Nucleic Acids and Stable Double-Stranded

RNA

-- Method of Minimizing Off-Target Effects of siRNA Molecules

-- Double-Stranded Ribonucleic Acid Molecules Having Ribothymidine

-- 5'-Methylpyrimidine and 2'-O-Methyl Ribonucleotide Modified Double

Stranded Ribonucleic Acid Molecules

-- Methods and Compositions for Enhancing Delivery of Double-Stranded RNA

or a Double-Stranded Hybrid Nucleic Acid to Regulate Gene Expression

in Mammalian Cells

-- Pharmaceutical Compositions for Delivery of Ribonucleic Acid to a Cell

-- Compositions and Methods for Enhancing Delivery of Nucleic Acids into

Cells and for Modifying Expression of Target Genes in Cells

-- Nanoparticles for Delivery of Nucleic Acids and Stable Double-Stranded

RNA

-- Compositions and Methods for Modulating Physiology of Epithelial

Junctional Adhesion Molecules for Enhanced Mucosal Delivery of

Therapeutic Comp
'/>"/>

SOURCE Nastech Pharmaceutical Company Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Nastech to Host 2007 Analyst and Institutional Investor Day
2. Nastech to Release Third Quarter Financial Results and Host Webcast on Monday, October 29, 2007
3. Nastech Announces Third Quarter 2007 Financial Results
4. Nastech to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference
5. Nastech to Present at BMO Capital Markets Focus on Healthcare Conference
6. Nastech Enters Into Feasibility Study to Develop a Non-Injectable Dosage Form of Factor IX to Control Bleeding
7. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
8. New property found in ancient mineral lodestone
9. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
10. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
11. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... (PRWEB) November 25, 2014 Miles Holder, ... joined the Graphel Carbon Products team as Sales/Marketing Manager. ... marketing, and customer service for the graphite industry. , ... to our team,” stated Dave Trinkley, VP of Market ... wide range of experience in the graphite industry, along ...
(Date:11/26/2014)... 2014 Theravalues Corporation est fier d,annoncer ... européen au salon Hi Europe 2014 (du 2 ... Curcumine la plus biodisponible actuellement sur ... à des ingrédients approuvés par les règlements européens. ... présent dans la racine de curcuma ( Curcuma ...
(Date:11/24/2014)... Nov. 24, 2014  IGI Laboratories, Inc. (NYSE MKT: ... specialty generic pharmaceutical company, today announced it has submitted ... U.S. Food and Drug Administration (FDA), which brings the ... seven, with eighteen submissions now pending at the FDA. ... CEO of the Company, commented, "Our team here at ...
(Date:11/24/2014)... , November 24, 2014   ... online on ScienceDirect   Elsevier , a ... services, is pleased to announce the launch of the latest ... Current Opinion in Food Science . ... will provide specialists with a new platform to keep up-to-date ...
Breaking Biology Technology:Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3IGI Laboratories, Inc. Announces ANDA Submission 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... Information technology professionals might know technology, but business executives ... the Fusion 2005 CEO-CIO Symposium said as they ... ways a chief information officer can hold sway in the ... into decision making, said John Byrnes, managing director of the ...
... investment, but with a good ROI strategy it doesn't have ... a tangible and timely return on investment (ROI). Your company's ... accountable members of its marketing team. Accountability is a good ... , ,ROI objectives can represent tangible things such as cost ...
... of tracking U.S. biotech financing in all its shapes and forms ... and Big Pharma). From its recent analysis, it would appear that ... the financing categories. Lets take a look: , , ... into the biotech sector from a variety of different sources, 2004 ...
Cached Biology Technology:CIOs learn boardroom-speak 2CIOs learn boardroom-speak 3How hard is your Web site working? 2How hard is your Web site working? 3How hard is your Web site working? 42004 a banner year for biotech financing 2
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
(Date:11/6/2014)... Except when that predator runs so fast that it essentially ... is the fastest creature on Earth. Some of these half-inch-long ... five miles per hour). The fastest human can do about ... tiger beetle, a person would have to hit 480 miles ... At peak speeds, everything becomes a blur. They can,t gather ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3The tiger beetle: Too fast to see 2
... Twenty environmental researchers from across North America have ... Based at Stanford University,s Woods Institute for ... in 1998 to help academic scientists make their ... the program selects up to 20 mid-career academic ...
... all holders of a valid press card / formal ... press facilities, including a working room and an interview ... to assist you in organising interviews with relevant experts. ... online at: http://www.eular.org/congress_press_registration.cfm , Please direct any ...
... Two Washington University in St. Louis scientists are imitating nature ... problems in orthopedic surgery: reattaching tendon to bone. Their ... repairs. The rotator cuff is the group of four tendons ... injured, the tendons tear or detach from the bone. ...
Cached Biology News:20 researchers selected as 2011 Leopold Leadership Fellows 220 researchers selected as 2011 Leopold Leadership Fellows 320 researchers selected as 2011 Leopold Leadership Fellows 4Biomimetic patch to be tested on tricky tendon-to-bone repairs 2Biomimetic patch to be tested on tricky tendon-to-bone repairs 3Biomimetic patch to be tested on tricky tendon-to-bone repairs 4
Mouse polyclonal antibody raised against a partial recombinant DDEF2. NCBI Entrez Gene ID = 8853...
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
... need to perform time consuming and inaccurate comparison ... any found variants of the sample when compared ... our mutation electropherogram as a sharp peak. ... mode is over 99%, with sensitivity to greater ...
Biology Products: